Cargando…

TRMT6 promotes hepatocellular carcinoma progression through the PI3K/AKT signaling pathway

BACKGROUND: Hepatocellular carcinoma is one of the most common and deadly cancers. The aim of this study was to elucidate the role of tRNA methyltransferase 6 (TRMT6) during HCC progression. METHODS: The role of TRMT6 in the progression and prognosis of HCC was confirmed by analysis of online databa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Yanqing, Liu, Maosheng, Wu, Fengfei, Ou, Shiyu, Wang, Weidong, Fei, Jieying, Xie, Fang, Bai, Lan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881333/ https://www.ncbi.nlm.nih.gov/pubmed/36707905 http://dx.doi.org/10.1186/s40001-022-00951-1

Ejemplares similares

S100A16 suppresses the proliferation, migration and invasion of colorectal cancer cells in part via the JNK/p38 MAPK pathway
por: Ou, Shiyu, et al.
Publicado: (2021)

Clinical Significance of TRMT6 in Hepatocellular Carcinoma: A Bioinformatics-Based Study
por: Wang, Yang, et al.
Publicado: (2019)

Functional characterization of the human tRNA methyltransferases TRMT10A and TRMT10B
por: Vilardo, Elisa, et al.
Publicado: (2020)

Distinct substrate specificities of the human tRNA methyltransferases TRMT10A and TRMT10B
por: Howell, Nathan W., et al.
Publicado: (2019)

Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway
por: Huang, Lu, et al.
Publicado: (2022)

Advanced oxidation protein products induce Paneth cells defects by endoplasmic reticulum stress in Crohn's disease
por: Shi, Jie, et al.
Publicado: (2023)

IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways
por: Duan, Shiyu, et al.
Publicado: (2018)

ADORA1 Promotes Hepatocellular Carcinoma Progression via PI3K/AKT Pathway
por: Ni, Sheng, et al.
Publicado: (2020)

Erratum to “Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway”
por: Huang, Lu, et al.
Publicado: (2022)

Trmt112 Gene Expression in Mouse Embryonic Development
por: Gu, Tiantian, et al.
Publicado: (2012)

Anhydroicaritin suppresses tumor progression via the PI3K/AKT signaling pathway in hepatocellular carcinoma
por: Wang, Houhong, et al.
Publicado: (2023)

BEZ235 Increases the Sensitivity of Hepatocellular Carcinoma to Sorafenib by Inhibiting PI3K/AKT/mTOR and Inducing Autophagy
por: Cao, Weiya, et al.
Publicado: (2021)

RGS20 Promotes Tumor Progression through Modulating PI3K/AKT Signaling Activation in Penile Cancer
por: Shi, Dazun, et al.
Publicado: (2022)

The role of the PI3K/AKT signalling pathway in the corneal epithelium: recent updates
por: Chen, Kuangqi, et al.
Publicado: (2022)

MARCH1 encourages tumour progression of hepatocellular carcinoma via regulation of PI3K‐AKT‐β‐catenin pathways
por: Xie, Lulu, et al.
Publicado: (2019)

EDG2 enhanced the progression of hepatocellular carcinoma by LPA/PI3K/AKT/ mTOR signaling
por: Xu, Meng, et al.
Publicado: (2017)

Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma
por: Sun, Eun Jin, et al.
Publicado: (2021)

PTEN regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression
por: Miller, Karina, et al.
Publicado: (2023)

Propofol suppresses adipose-derived stem cell progression via PI3K/AKT-Wnt signaling pathway
por: Yin, Guoping, et al.
Publicado: (2022)

ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway
por: Chen, Han, et al.
Publicado: (2020)

Celastrus orbiculatus extract triggers apoptosis and autophagy via PI3K/Akt/mTOR inhibition in human colorectal cancer cells
por: Yang, Lin, et al.
Publicado: (2016)

Vertical blockade of the IGFR- PI3K/Akt/mTOR pathway for the treatment of hepatocellular carcinoma: the role of survivin
por: Ou, Da-Liang, et al.
Publicado: (2014)

NCAPG Promotes The Proliferation Of Hepatocellular Carcinoma Through PI3K/AKT Signaling
por: Gong, Chengwu, et al.
Publicado: (2019)

The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism
por: Tian, Ling-Yu, et al.
Publicado: (2023)

Targeting EGFR/PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma
por: Bang, Jieun, et al.
Publicado: (2023)

MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway
por: Zhang, Zhenyu, et al.
Publicado: (2018)

HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways
por: Li, Qing, et al.
Publicado: (2018)

Retraction: MicroRNA-367 promotes progression of hepatocellular carcinoma through PTEN/PI3K/AKT signaling pathway
Publicado: (2020)

Pre-mRNA Processing Factor 8 Accelerates the Progression of Hepatocellular Carcinoma by Regulating the PI3K/Akt Pathway
por: Wang, Shouhan, et al.
Publicado: (2020)

Ligand-activated PPARδ expression promotes hepatocellular carcinoma progression by regulating the PI3K-AKT signaling pathway
por: Han, Wei, et al.
Publicado: (2022)

VCP interaction with HMGB1 promotes hepatocellular carcinoma progression by activating the PI3K/AKT/mTOR pathway
por: Pu, Zhangya, et al.
Publicado: (2022)

Up-Regulation of RACGAP1 Promotes Progressions of Hepatocellular Carcinoma Regulated by GABPA via PI3K/AKT Pathway
por: Gu, Yang, et al.
Publicado: (2022)

Overexpression of YEATS2 Remodels the Extracellular Matrix to Promote Hepatocellular Carcinoma Progression via the PI3K/AKT Pathway
por: Liu, Xin, et al.
Publicado: (2023)

Simvastatin improves the homing of BMSCs via the PI3K/AKT/miR‐9 pathway
por: Bing, Weidong, et al.
Publicado: (2016)

Knockdown of FUT11 inhibits the progression of gastric cancer via the PI3K/AKT pathway
por: Cao, Wenpeng, et al.
Publicado: (2023)

Pan-Cancer Analysis Reveals the Relation between TRMT112 and Tumor Microenvironment
por: Xu, Haitao, et al.
Publicado: (2022)

Human TRMT2A methylates tRNA and contributes to translation fidelity
por: Witzenberger, Monika, et al.
Publicado: (2023)

The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer
por: Dobbin, Zachary C., et al.
Publicado: (2013)

Research progress on the PI3K/AKT signaling pathway in gynecological cancer
por: Shi, Xiang, et al.
Publicado: (2019)

Midkine promotes glioblastoma progression via PI3K-Akt signaling
por: Hu, Beiquan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e1da63gt8fndsdoc6b9ff7158a